IL-12 stimulates T lymphocytes and natural killer cells to release interferon gamma (IFN-γ), which has been shown with the capability to inhibit tumor growth, angiogenesis, and metastasis both in rodents and human [12], [13]. The gene discussed is IFNG; the disease is neoplasm.